Advisor Group’s Globus Medical GMED Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2019
Q4
$188K Sell
3,198
-929
-23% -$50.4K ﹤0.01% 2438
2019
Q3
$211K Buy
4,127
+1,175
+40% +$56K ﹤0.01% 2286
2019
Q2
$124K Sell
2,952
-691
-19% -$30K ﹤0.01% 2693
2019
Q1
$181K Sell
3,643
-670
-16% -$30.3K ﹤0.01% 2363
2018
Q4
$187K Buy
4,313
+1,656
+62% +$82.6K ﹤0.01% 2138
2018
Q3
$151K Buy
2,657
+76
+3% +$4K ﹤0.01% 2398
2018
Q2
$130K Sell
2,581
-813
-24% -$42.4K ﹤0.01% 2307
2018
Q1
$169K Sell
3,394
-336
-9% -$15.8K ﹤0.01% 2104
2017
Q4
$153K Buy
3,730
+201
+6% +$7.04K ﹤0.01% 2215
2017
Q3
$105K Buy
3,529
+95
+3% +$2.9K ﹤0.01% 2355
2017
Q2
$114K Buy
3,434
+68
+2% +$2.14K ﹤0.01% 2199
2017
Q1
$100K Buy
3,366
+153
+5% +$4.18K ﹤0.01% 2148
2016
Q4
$80K Buy
3,213
+1,445
+82% +$32.8K ﹤0.01% 2228
2016
Q3
$40K Sell
1,768
-3,024
-63% -$71.1K ﹤0.01% 2694
2016
Q2
$112K Buy
+4,792
New +$115K ﹤0.01% 1844

Other funds holding GMED

Advisor Group's GMED Position: Q4 2019 in Review

Advisor Group reduced its Globus Medical (GMED) stake by 23% in Q4 2019, selling an estimated $50.4K and leaving 3,198 shares worth $188K. The position accounts for ﹤0.01% of the portfolio, ranked #2438.

Advisor Group first reported a position in GMED in Q2 2016 and has held it in 15 quarters since. The position peaked at $211K in Q3 2019. 307 funds tracked by Wall St. Rank hold GMED as of Q4 2019.

  • Advisor Group held 3,198 shares of Globus Medical worth $188K as of Q4 2019.
  • Advisor Group sold 929 Globus Medical shares in Q4 2019, an estimated $50.4K.
  • Globus Medical made up ﹤0.01% of Advisor Group's portfolio in Q4 2019, its #2438 holding.
  • Advisor Group first reported a position in Globus Medical in Q2 2016 and has held it in 15 quarters since.
  • Advisor Group's Globus Medical position peaked at $211K in Q3 2019.
  • 307 funds tracked by Wall St. Rank held Globus Medical as of Q4 2019.

Based on Advisor Group's 13F filing for Q4 2019, filed 12 Feb 2020.